NCT04910633
- Conditions
- COVID-19, Cancer, Coronaviridae Infections, +13 more
- Locations
-
- Lyon University Hospital Cancer Institute Bron, France
Clinical trial condition
Solid Tumor
Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.
717 public trials
251 recruiting studies
Solid Tumor trial results
Completed
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
NCT03359850
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Atlanta, Georgia, United States
NCT04419623
- Conditions
- Blood Cancer, COVID-19, Cancer, +21 more
- Locations
-
- Georgia Cancer Center Augusta, Georgia, United States
- The Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
NCT03406364
- Conditions
- Solid Tumor
- Locations
-
- Tri-Service General Hospital Taipei, Nehu District, Taiwan
NCT02953782
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
- Locations
-
- UCLA Los Angeles, California, United States
- Stanford University Palo Alto, California, United States
- Wayne State University Detroit, Michigan, United States
- START Midwest Grand Rapids, Michigan, United States
NCT02273739
- Conditions
- Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
- Locations
-
- Los Angeles, California, United States
- Los Angeles, California, United States
- Miami, Florida, United States
- Baltimore, Maryland, United States
NCT03489369
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT00786669
- Conditions
- Solid Tumor
- Locations
-
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
NCT02132754
- Conditions
- Solid Tumor
- Locations
-
Not specified
Completed
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
NCT01432951
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China